nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—FMO3—urine—polycystic ovary syndrome	0.0506	0.176	CbGeAlD
Almotriptan—CYP2C19—urine—polycystic ovary syndrome	0.0224	0.0778	CbGeAlD
Almotriptan—CYP1A2—urine—polycystic ovary syndrome	0.0183	0.0636	CbGeAlD
Almotriptan—CYP2E1—urine—polycystic ovary syndrome	0.0164	0.0572	CbGeAlD
Almotriptan—Melatonin—MTNR1B—polycystic ovary syndrome	0.0137	0.68	CrCbGaD
Almotriptan—FMO3—adrenal cortex—polycystic ovary syndrome	0.0134	0.0466	CbGeAlD
Almotriptan—CYP3A4—urine—polycystic ovary syndrome	0.0132	0.046	CbGeAlD
Almotriptan—CYP2D6—urine—polycystic ovary syndrome	0.013	0.0453	CbGeAlD
Almotriptan—FMO3—pituitary gland—polycystic ovary syndrome	0.0108	0.0377	CbGeAlD
Almotriptan—FMO3—adipose tissue—polycystic ovary syndrome	0.0108	0.0375	CbGeAlD
Almotriptan—FMO3—adrenal gland—polycystic ovary syndrome	0.00968	0.0337	CbGeAlD
Almotriptan—FMO3—vagina—polycystic ovary syndrome	0.00897	0.0312	CbGeAlD
Almotriptan—FMO3—endocrine gland—polycystic ovary syndrome	0.0084	0.0292	CbGeAlD
Almotriptan—Neuropathy—Metformin—polycystic ovary syndrome	0.00756	0.0444	CcSEcCtD
Almotriptan—MAOA—embryo—polycystic ovary syndrome	0.00708	0.0246	CbGeAlD
Almotriptan—Ear pain—Metformin—polycystic ovary syndrome	0.00685	0.0403	CcSEcCtD
Almotriptan—Pain in extremity—Metformin—polycystic ovary syndrome	0.00585	0.0344	CcSEcCtD
Almotriptan—MAOA—adrenal cortex—polycystic ovary syndrome	0.0058	0.0202	CbGeAlD
Almotriptan—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00534	0.0314	CcSEcCtD
Almotriptan—Breast disorder—Metformin—polycystic ovary syndrome	0.00528	0.031	CcSEcCtD
Almotriptan—MAOA—endometrium—polycystic ovary syndrome	0.00518	0.018	CbGeAlD
Almotriptan—HTR1B—endocrine gland—polycystic ovary syndrome	0.00493	0.0171	CbGeAlD
Almotriptan—Angina pectoris—Metformin—polycystic ovary syndrome	0.00492	0.0289	CcSEcCtD
Almotriptan—Sweating increased—Metformin—polycystic ovary syndrome	0.00492	0.0289	CcSEcCtD
Almotriptan—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00484	0.0285	CcSEcCtD
Almotriptan—MAOA—uterus—polycystic ovary syndrome	0.00477	0.0166	CbGeAlD
Almotriptan—MAOA—pituitary gland—polycystic ovary syndrome	0.00469	0.0163	CbGeAlD
Almotriptan—MAOA—adipose tissue—polycystic ovary syndrome	0.00467	0.0162	CbGeAlD
Almotriptan—CYP2C8—endometrium—polycystic ovary syndrome	0.00462	0.0161	CbGeAlD
Almotriptan—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00442	0.026	CcSEcCtD
Almotriptan—MAOA—adrenal gland—polycystic ovary syndrome	0.00419	0.0146	CbGeAlD
Almotriptan—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00418	0.0145	CbGeAlD
Almotriptan—Rhinitis—Metformin—polycystic ovary syndrome	0.00405	0.0238	CcSEcCtD
Almotriptan—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00402	0.0236	CcSEcCtD
Almotriptan—CYP2C19—vagina—polycystic ovary syndrome	0.00396	0.0138	CbGeAlD
Almotriptan—MAOA—female gonad—polycystic ovary syndrome	0.00391	0.0136	CbGeAlD
Almotriptan—MAOA—vagina—polycystic ovary syndrome	0.00388	0.0135	CbGeAlD
Almotriptan—Eye disorder—Metformin—polycystic ovary syndrome	0.00378	0.0222	CcSEcCtD
Almotriptan—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00375	0.0221	CcSEcCtD
Almotriptan—Melatonin—CYP19A1—polycystic ovary syndrome	0.00373	0.185	CrCbGaD
Almotriptan—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00371	0.0129	CbGeAlD
Almotriptan—Immune system disorder—Metformin—polycystic ovary syndrome	0.00365	0.0215	CcSEcCtD
Almotriptan—MAOA—endocrine gland—polycystic ovary syndrome	0.00363	0.0126	CbGeAlD
Almotriptan—Chills—Metformin—polycystic ovary syndrome	0.00363	0.0213	CcSEcCtD
Almotriptan—Erythema—Metformin—polycystic ovary syndrome	0.00352	0.0207	CcSEcCtD
Almotriptan—CYP2C8—vagina—polycystic ovary syndrome	0.00346	0.012	CbGeAlD
Almotriptan—Dysgeusia—Metformin—polycystic ovary syndrome	0.00345	0.0203	CcSEcCtD
Almotriptan—Vision blurred—Metformin—polycystic ovary syndrome	0.00332	0.0195	CcSEcCtD
Almotriptan—Tremor—Metformin—polycystic ovary syndrome	0.0033	0.0194	CcSEcCtD
Almotriptan—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00327	0.0192	CcSEcCtD
Almotriptan—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00324	0.0113	CbGeAlD
Almotriptan—Malaise—Metformin—polycystic ovary syndrome	0.00317	0.0187	CcSEcCtD
Almotriptan—Syncope—Metformin—polycystic ovary syndrome	0.00316	0.0186	CcSEcCtD
Almotriptan—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00314	0.0109	CbGeAlD
Almotriptan—Palpitations—Metformin—polycystic ovary syndrome	0.00311	0.0183	CcSEcCtD
Almotriptan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00309	0.0182	CcSEcCtD
Almotriptan—Hypertension—Metformin—polycystic ovary syndrome	0.00304	0.0179	CcSEcCtD
Almotriptan—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00303	0.0105	CbGeAlD
Almotriptan—Myalgia—Metformin—polycystic ovary syndrome	0.003	0.0176	CcSEcCtD
Almotriptan—Chest pain—Metformin—polycystic ovary syndrome	0.003	0.0176	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00298	0.0175	CcSEcCtD
Almotriptan—Discomfort—Metformin—polycystic ovary syndrome	0.00296	0.0174	CcSEcCtD
Almotriptan—Shock—Metformin—polycystic ovary syndrome	0.00283	0.0166	CcSEcCtD
Almotriptan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00282	0.0166	CcSEcCtD
Almotriptan—Skin disorder—Metformin—polycystic ovary syndrome	0.00279	0.0164	CcSEcCtD
Almotriptan—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00278	0.0163	CcSEcCtD
Almotriptan—Melatonin—CYP1A1—polycystic ovary syndrome	0.00274	0.136	CrCbGaD
Almotriptan—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00273	0.00948	CbGeAlD
Almotriptan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00262	0.0154	CcSEcCtD
Almotriptan—Paraesthesia—Metformin—polycystic ovary syndrome	0.00258	0.0152	CcSEcCtD
Almotriptan—Dyspnoea—Metformin—polycystic ovary syndrome	0.00256	0.0151	CcSEcCtD
Almotriptan—Somnolence—Metformin—polycystic ovary syndrome	0.00255	0.015	CcSEcCtD
Almotriptan—Dyspepsia—Metformin—polycystic ovary syndrome	0.00253	0.0149	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00248	0.0146	CcSEcCtD
Almotriptan—Fatigue—Metformin—polycystic ovary syndrome	0.00248	0.0146	CcSEcCtD
Almotriptan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00237	0.0139	CcSEcCtD
Almotriptan—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00235	0.0138	CcSEcCtD
Almotriptan—CYP2D6—female gonad—polycystic ovary syndrome	0.00232	0.00807	CbGeAlD
Almotriptan—Abdominal pain—Metformin—polycystic ovary syndrome	0.00227	0.0133	CcSEcCtD
Almotriptan—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00219	0.00763	CbGeAlD
Almotriptan—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00216	0.00751	CbGeAlD
Almotriptan—Asthenia—Metformin—polycystic ovary syndrome	0.00206	0.0121	CcSEcCtD
Almotriptan—Pruritus—Metformin—polycystic ovary syndrome	0.00203	0.0119	CcSEcCtD
Almotriptan—Diarrhoea—Metformin—polycystic ovary syndrome	0.00197	0.0116	CcSEcCtD
Almotriptan—Dizziness—Metformin—polycystic ovary syndrome	0.0019	0.0112	CcSEcCtD
Almotriptan—Vomiting—Metformin—polycystic ovary syndrome	0.00183	0.0107	CcSEcCtD
Almotriptan—Rash—Metformin—polycystic ovary syndrome	0.00181	0.0106	CcSEcCtD
Almotriptan—Dermatitis—Metformin—polycystic ovary syndrome	0.00181	0.0106	CcSEcCtD
Almotriptan—Headache—Metformin—polycystic ovary syndrome	0.0018	0.0106	CcSEcCtD
Almotriptan—Nausea—Metformin—polycystic ovary syndrome	0.00171	0.01	CcSEcCtD
Almotriptan—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000137	0.000262	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000136	0.000261	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INSR—polycystic ovary syndrome	0.000135	0.000259	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000135	0.000258	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PPARG—polycystic ovary syndrome	0.000134	0.000256	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000133	0.000256	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000133	0.000254	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000133	0.000254	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000132	0.000254	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—POMC—polycystic ovary syndrome	0.000132	0.000253	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—INS—polycystic ovary syndrome	0.000131	0.000252	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.00013	0.00025	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000128	0.000246	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000127	0.000242	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000126	0.000242	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000126	0.000241	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PGR—polycystic ovary syndrome	0.000125	0.00024	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000125	0.00024	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000125	0.000239	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000125	0.000239	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000124	0.000238	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000124	0.000237	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000124	0.000237	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000123	0.000235	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000118	0.000227	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000118	0.000226	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000116	0.000223	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000116	0.000223	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000116	0.000222	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000116	0.000222	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000115	0.00022	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—TH—polycystic ovary syndrome	0.000115	0.00022	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000114	0.000218	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000114	0.000218	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000114	0.000217	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000113	0.000217	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000113	0.000217	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000113	0.000216	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000113	0.000216	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000112	0.000215	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000112	0.000214	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000112	0.000214	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000112	0.000214	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000111	0.000213	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000111	0.000212	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00011	0.00021	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00011	0.00021	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000109	0.000209	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000109	0.000208	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000108	0.000207	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000108	0.000206	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000108	0.000206	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000107	0.000206	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000106	0.000204	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000106	0.000203	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000106	0.000202	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000105	0.000202	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000105	0.000201	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000105	0.000201	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000104	0.000199	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000102	0.000196	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000102	0.000195	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PRL—polycystic ovary syndrome	0.000102	0.000194	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000101	0.000193	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000101	0.000193	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.0001	0.000192	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	9.97e-05	0.000191	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	9.94e-05	0.00019	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	9.89e-05	0.000189	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	9.81e-05	0.000188	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.79e-05	0.000187	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	9.73e-05	0.000186	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.63e-05	0.000185	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	9.6e-05	0.000184	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	9.59e-05	0.000184	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.58e-05	0.000184	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	9.58e-05	0.000183	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.49e-05	0.000182	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.43e-05	0.000181	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GNAS—polycystic ovary syndrome	9.37e-05	0.00018	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	9.29e-05	0.000178	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	9.26e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	9.23e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	9.22e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.96e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.96e-05	0.000172	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GNAS—polycystic ovary syndrome	8.93e-05	0.000171	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	8.93e-05	0.000171	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	8.87e-05	0.00017	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	8.83e-05	0.000169	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	8.8e-05	0.000169	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	8.76e-05	0.000168	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	8.76e-05	0.000168	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	8.75e-05	0.000168	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.7e-05	0.000167	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	8.56e-05	0.000164	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	8.55e-05	0.000164	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.51e-05	0.000163	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	8.47e-05	0.000162	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NRG1—polycystic ovary syndrome	8.35e-05	0.00016	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.33e-05	0.00016	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	8.29e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	8.28e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	8.27e-05	0.000158	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	8.18e-05	0.000157	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	8.14e-05	0.000156	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	8.05e-05	0.000154	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	7.98e-05	0.000153	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	7.89e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	7.87e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	7.84e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	7.67e-05	0.000147	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	7.63e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	7.62e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.62e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	7.57e-05	0.000145	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.52e-05	0.000144	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.51e-05	0.000144	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	7.48e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.4e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	7.39e-05	0.000141	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IRS2—polycystic ovary syndrome	7.16e-05	0.000137	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	7.15e-05	0.000137	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	7.12e-05	0.000136	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	7.12e-05	0.000136	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TH—polycystic ovary syndrome	7.05e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	7.04e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	7.02e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.01e-05	0.000134	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	7.01e-05	0.000134	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LEP—polycystic ovary syndrome	7e-05	0.000134	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	6.86e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	6.85e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	6.84e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	6.82e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.8e-05	0.00013	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	6.8e-05	0.00013	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.79e-05	0.00013	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	6.76e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.71e-05	0.000128	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	6.67e-05	0.000128	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	6.55e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	6.46e-05	0.000124	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	6.44e-05	0.000123	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARG—polycystic ovary syndrome	6.4e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	6.38e-05	0.000122	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—POMC—polycystic ovary syndrome	6.31e-05	0.000121	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	6.29e-05	0.000121	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	6.28e-05	0.00012	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—INS—polycystic ovary syndrome	6.28e-05	0.00012	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	6.25e-05	0.00012	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	6.22e-05	0.000119	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	6.12e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TH—polycystic ovary syndrome	6.09e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.05e-05	0.000116	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	6.02e-05	0.000115	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	5.98e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	5.94e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	5.92e-05	0.000113	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	5.89e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	5.87e-05	0.000112	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	5.86e-05	0.000112	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	5.79e-05	0.000111	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	5.78e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	5.78e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.77e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	5.76e-05	0.00011	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	5.75e-05	0.00011	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	5.67e-05	0.000108	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	5.66e-05	0.000108	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.57e-05	0.000107	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	5.55e-05	0.000106	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.49e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	5.48e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TH—polycystic ovary syndrome	5.44e-05	0.000104	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.38e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	5.33e-05	0.000102	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.3e-05	0.000102	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	5.29e-05	0.000101	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.27e-05	0.000101	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	5.27e-05	0.000101	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.23e-05	0.0001	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	5.19e-05	9.95e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.15e-05	9.86e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TH—polycystic ovary syndrome	5e-05	9.57e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.98e-05	9.55e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.97e-05	9.52e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.97e-05	9.52e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	4.97e-05	9.52e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	4.89e-05	9.37e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	4.86e-05	9.31e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	4.84e-05	9.27e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.74e-05	9.07e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.59e-05	8.79e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	4.57e-05	8.76e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.49e-05	8.6e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.44e-05	8.51e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	4.44e-05	8.5e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	4.42e-05	8.47e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.33e-05	8.3e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.28e-05	8.2e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TH—polycystic ovary syndrome	4.24e-05	8.11e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	4.23e-05	8.1e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	4.19e-05	8.02e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	4.12e-05	7.89e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.11e-05	7.88e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	4.08e-05	7.82e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.06e-05	7.78e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	4.01e-05	7.67e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	3.93e-05	7.52e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.89e-05	7.45e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.87e-05	7.42e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	3.87e-05	7.42e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INS—polycystic ovary syndrome	3.85e-05	7.38e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.84e-05	7.35e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.78e-05	7.24e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.78e-05	7.23e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.74e-05	7.15e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.7e-05	7.09e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.69e-05	7.06e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	3.46e-05	6.62e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	3.44e-05	6.58e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.39e-05	6.5e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.35e-05	6.41e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.33e-05	6.38e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	3.29e-05	6.31e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.27e-05	6.26e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.18e-05	6.09e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.12e-05	5.98e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	3.03e-05	5.8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.99e-05	5.73e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.99e-05	5.72e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.97e-05	5.69e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.91e-05	5.57e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.79e-05	5.34e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.75e-05	5.26e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.73e-05	5.23e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.67e-05	5.11e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	2.61e-05	5.01e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.56e-05	4.9e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.54e-05	4.87e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.41e-05	4.62e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.36e-05	4.52e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.33e-05	4.46e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.32e-05	4.43e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.25e-05	4.3e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.82e-05	3.49e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.8e-05	3.44e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.79e-05	3.42e-05	CbGpPWpGaD
